NCT05966766

Brief Summary

This is a clinical study that aims to determine the effective dose of music listening duration that is required to reduce anxiety in patients awaiting scheduled cesarean section. It will also compare types of music to accomplish this goal, both of which have been shown effective in prior studies. Methods will involve enrolling and playing music for patients awaiting scheduled C-section, and scoring their anxiety with pre- and post-music questionnaires. Music duration for each subject will be predetermined, and analysis of response will be performed to determine the effective dose 95%, or dose at which 95% of subjects should have a positive response.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

December 7, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
12 months until next milestone

Results Posted

Study results publicly available

May 30, 2025

Completed
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

July 20, 2023

Results QC Date

February 10, 2025

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anxiety Score

    Verbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.

    4-8 minutes

Secondary Outcomes (1)

  • STAI

    4-8 minutes

Study Arms (2)

Mozart

ACTIVE COMPARATOR

Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.

Other: Mozart selections

Patient preference

ACTIVE COMPARATOR

Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.

Other: Patient-preferred music selections

Interventions

Music will be played from a speaker connected to a media-playing device for participants to listen to for set durations of time. Music will be selections by Mozart of previously studied and shown to reduce anxiety.

Mozart

Music will be played from a speaker connected to a media-playing device for participants to listen to for set durations of time. Music will be selections of patient choice.

Patient preference

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Planning on scheduled cesarean section or non-emergent unscheduled cesarean section
  • Able to provide informed consent
  • American Society of Anaesthesiologists (ASA) physical status score of II-III

You may not qualify if:

  • Patient refusal
  • Impaired hearing
  • Patient is taking at least one anxiolytic medication daily at baseline
  • No anxiety (a score of 0, on a scale of 0-10, of pre-music exposure anxiety) after consent is given
  • ASA IV or higher

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Limitations and Caveats

Minimum required number of participants recruited was achieved. Larger sample sizes may have yielded results of stronger statistical significance.

Results Point of Contact

Title
Dan Drzymalski, MD
Organization
Tufts Medical Center

Study Officials

  • Dan Drzymalski, MD

    Tufts Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 1, 2023

Study Start

December 7, 2023

Primary Completion

May 31, 2024

Study Completion

May 31, 2024

Last Updated

May 30, 2025

Results First Posted

May 30, 2025

Record last verified: 2025-05

Locations